Sood AK - Search Results

1

Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer.

Landen CN, Merritt WM, Mangala LS, Sanguino AM, Bucana C, Lu C, Lin YG, Han LY, Kamat AA, Schmandt R, Coleman RL, Gershenson DM, Lopez-Berestein G, Sood AK. Landen CN, et al. Among authors: sood ak. Cancer Biol Ther. 2006 Dec;5(12):1708-13. doi: 10.4161/cbt.5.12.3468. Epub 2006 Dec 30. Cancer Biol Ther. 2006. PMID: 17106249

2

p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma.

Sood AK, Coffin J, Jabbari S, Buller RE, Hendrix MJ, Klingelhutz A. Sood AK, et al. Cancer Biol Ther. 2002 Sep-Oct;1(5):511-7. doi: 10.4161/cbt.1.5.167. Cancer Biol Ther. 2002. PMID: 12496479

3

The clinical significance of tumor cell-lined vasculature in ovarian carcinoma: implications for anti-vasculogenic therapy.

Sood AK, Fletcher MS, Zahn CM, Gruman LM, Coffin JE, Seftor EA, Hendrix MJ. Sood AK, et al. Cancer Biol Ther. 2002 Nov-Dec;1(6):661-4. doi: 10.4161/cbt.316. Cancer Biol Ther. 2002. PMID: 12642690

4

The complexity of tumor vascularity.

Sood AK, Hendrix MJ. Sood AK, et al. Cancer Biol Ther. 2003 May-Jun;2(3):257-8. Cancer Biol Ther. 2003. PMID: 12878860 No abstract available.

5

Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.

Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM, Hendrix MJ. Sood AK, et al. Am J Obstet Gynecol. 2004 Apr;190(4):899-909. doi: 10.1016/j.ajog.2004.02.011. Am J Obstet Gynecol. 2004. PMID: 15118611

6

EphA2 expression is associated with aggressive features in ovarian carcinoma.

Thaker PH, Deavers M, Celestino J, Thornton A, Fletcher MS, Landen CN, Kinch MS, Kiener PA, Sood AK. Thaker PH, et al. Among authors: sood ak. Clin Cancer Res. 2004 Aug 1;10(15):5145-50. doi: 10.1158/1078-0432.CCR-03-0589. Clin Cancer Res. 2004. PMID: 15297418

7

Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion.

Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, Gershenson DM, Schaller MD, Hendrix MJ. Sood AK, et al. Am J Pathol. 2004 Oct;165(4):1087-95. doi: 10.1016/S0002-9440(10)63370-6. Am J Pathol. 2004. PMID: 15466376 Free PMC article.

8

Genomic instability is associated with lack of telomerase activation in ovarian cancer.

Landen CN, Klingelhutz A, Coffin JE, Sorosky JI, Sood AK. Landen CN, et al. Among authors: sood ak. Cancer Biol Ther. 2004 Dec;3(12):1250-3. doi: 10.4161/cbt.3.12.1235. Epub 2004 Dec 14. Cancer Biol Ther. 2004. PMID: 15477760

9

Fifth International Conference on Ovarian Cancer: challenges and opportunities.

Sood AK, Abu-Rustum NR, Barakat RR, Bodurka DC, Brown J, Donato ML, Poynor EA, Wolf JK, Gershenson DM. Sood AK, et al. Gynecol Oncol. 2005 Jun;97(3):916-23. doi: 10.1016/j.ygyno.2005.03.013. Gynecol Oncol. 2005. PMID: 15907981

10

Selected highlights from the 5th International Conference on Ovarian Cancer. Houston, TX, USA, 1-4 December 2004.

Sood AK, Coleman RL, Wolf JK, Gershenson DM. Sood AK, et al. Expert Opin Pharmacother. 2005 Jun;6(7):1269-75. doi: 10.1517/14656566.6.7.1269. Expert Opin Pharmacother. 2005. PMID: 15957979 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,140 results

Search Page